Our study showed reduced CD4+ T cells, IFN-γ, and TNF-α and identification of peripheral immune related genes in sarcoma patients compared to healthy controls, indicating reduced anti-cancer immunity in these patients. This evidence concerns the gene CD4 and cancer.